Cordlife Group Ltd
SGX:P8A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cordlife Group Ltd
Total Current Assets
Cordlife Group Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cordlife Group Ltd
SGX:P8A
|
Total Current Assets
S$107.8m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Q & M Dental Group (Singapore) Ltd
SGX:QC7
|
Total Current Assets
S$178.1m
|
CAGR 3-Years
30%
|
CAGR 5-Years
16%
|
CAGR 10-Years
6%
|
|
|
Alliance Healthcare Group Ltd
SGX:MIJ
|
Total Current Assets
S$69.9m
|
CAGR 3-Years
20%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
T
|
Talkmed Group Ltd
SGX:5G3
|
Total Current Assets
S$97.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
A
|
Aoxin Q & M Dental Group Ltd
SGX:1D4
|
Total Current Assets
¥209.4m
|
CAGR 3-Years
35%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
HC Surgical Specialists Ltd
SGX:1B1
|
Total Current Assets
S$9.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Cordlife Group Ltd
Glance View
Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
See Also
What is Cordlife Group Ltd's Total Current Assets?
Total Current Assets
107.8m
SGD
Based on the financial report for Dec 31, 2025, Cordlife Group Ltd's Total Current Assets amounts to 107.8m SGD.
What is Cordlife Group Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
1%
Over the last year, the Total Current Assets growth was 0%.
